CRS(CRS)
CRS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.48B | $3.83B | $4.22B | $4.50B | $4.73B |
| Low | $3.42B | $3.72B | $4.05B | $4.32B | $4.54B |
| High | $3.54B | $3.94B | $4.38B | $4.67B | $4.91B |
| EBITDA Avg | $1.65B | $1.81B | $2.00B | $2.13B | $2.24B |
| Low | $1.62B | $1.76B | $1.92B | $2.04B | $2.15B |
| High | $1.67B | $1.86B | $2.07B | $2.21B | $2.32B |
| EBIT Avg | $1.54B | $1.70B | $1.87B | $2.00B | $2.10B |
| Low | $1.52B | $1.65B | $1.80B | $1.92B | $2.01B |
| High | $1.57B | $1.75B | $1.94B | $2.07B | $2.18B |
| Net Income Avg | $660M | $791M | $968M | $1.05B | $1.12B |
| Low | $628M | $756M | $916M | $997M | $1.06B |
| High | $692M | $826M | $1.01B | $1.10B | $1.18B |
| EPS Avg | $13.21 | $15.92 | $19.20 | $20.90 | $22.30 |
| Low | $12.45 | $14.99 | $18.18 | $19.79 | $21.12 |
| High | $13.74 | $16.39 | $20.13 | $21.91 | $23.38 |
| Analysts (Rev / EPS) | 6 / 5 | 4 / 4 | 2 / 1 | 2 / 1 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $823M | $814M | $904M | $945M | $916M | $910M | $1.00B | $1.03B |
| Low | $809M | $806M | $879M | $918M | $891M | $885M | $974M | $997M |
| High | $836M | $823M | $928M | $970M | $940M | $934M | $1.03B | $1.05B |
| EBITDA Avg | $389M | $385M | $428M | $447M | $433M | $431M | $474M | $485M |
| Low | $383M | $381M | $416M | $435M | $421M | $419M | $461M | $472M |
| High | $395M | $390M | $439M | $459M | $445M | $442M | $487M | $498M |
| EBIT Avg | $365M | $362M | $401M | $419M | $407M | $404M | $445M | $455M |
| Low | $359M | $358M | $390M | $408M | $395M | $393M | $432M | $442M |
| High | $371M | $366M | $412M | $430M | $417M | $415M | $456M | $467M |
| Net Income Avg | $149M | $150M | $173M | $189M | $180M | $181M | $209M | $235M |
| Low | $144M | $145M | $167M | $182M | $173M | $174M | $201M | $226M |
| High | $155M | $157M | $179M | $195M | $186M | $187M | $216M | $243M |
| EPS Avg | $2.96 | $2.98 | $3.44 | $3.74 | $3.56 | $3.58 | $4.14 | $4.66 |
| Low | $2.86 | $2.87 | $3.31 | $3.61 | $3.44 | $3.45 | $3.99 | $4.49 |
| High | $3.07 | $3.11 | $3.55 | $3.87 | $3.69 | $3.71 | $4.28 | $4.82 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 2 | 3 / 2 |